NPI: 1053387738 · ROCKY HILL, CT 06067 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,134 | $152K |
| 2019 | 9,465 | $83K |
| 2020 | 5,620 | $28K |
| 2021 | 2,043 | $13K |
| 2022 | 3,122 | $47K |
| 2023 | 1,777 | $79K |
| 2024 | 3,539 | $253K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,575 | 1,585 | $493K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,053 | 618 | $39K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 210 | 127 | $32K |
| 82728 | 198 | 165 | $23K | |
| 83970 | 206 | 168 | $15K | |
| 83550 | 226 | 185 | $12K | |
| 83540 | 227 | 186 | $10K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,898 | 525 | $9K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,157 | 125 | $7K |
| 82108 | 19 | 14 | $5K | |
| 85041 | 492 | 428 | $4K | |
| 85048 | 492 | 428 | $3K | |
| A4657 | Syringe, with or without needle, each | 674 | 580 | $3K |
| J1644 | Injection, heparin sodium, per 1000 units | 1,191 | 108 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 82 | 44 | $0.00 |